David A. Siegel Aquestive Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

$41.3 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$2.31 - $4.5 $21,714 - $42,300	9,400 Added 63.51%	24,200 $62,000
Q1 2024 May 15, 2024	SELL	$2.01 - $6.09 $24,119 - $73,080	-12,000 Reduced 44.78%	14,800 $63,000
Q4 2023 Feb 14, 2024	SELL	$1.29 - $2.47 $4,257 - $8,151	-3,300 Reduced 10.96%	26,800 $54,000
Q3 2023 Nov 14, 2023	BUY	$1.5 - $2.24 $2,550 - $3,808	1,700 Added 5.99%	30,100 $46,000
Q2 2023 Aug 14, 2023	BUY	$1.06 - $2.49 $5,618 - $13,197	5,300 Added 22.94%	28,400 $46,000
Q1 2023 May 15, 2023	SELL	$0.72 - $1.15 $6,696 - $10,695	-9,300 Reduced 28.7%	23,100 $26,000
Q4 2022 Feb 14, 2023	SELL	$0.77 - $1.18 $5,775 - $8,850	-7,500 Reduced 18.8%	32,400 $29,000
Q3 2022 Nov 14, 2022	SELL	$0.63 - $1.73 $5,040 - $13,840	-8,000 Reduced 16.7%	39,900 $47,000
Q2 2022 Aug 15, 2022	SELL	$0.64 - $2.57 $2,880 - $11,565	-4,500 Reduced 8.59%	47,900 $31,000
Q1 2022 May 16, 2022	SELL	$2.28 - $4.26 $21,431 - $40,044	-9,400 Reduced 15.21%	52,400 $137,000
Q4 2021 Feb 14, 2022	BUY	$3.69 - $6.37 $53,505 - $92,365	14,500 Added 30.66%	61,800 $240,000
Q3 2021 Nov 15, 2021	BUY	$3.25 - $4.66 $35,425 - $50,794	10,900 Added 29.95%	47,300 $206,000
Q2 2021 Aug 16, 2021	BUY	$3.29 - $5.21 $82,908 - $131,292	25,200 Added 225.0%	36,400 $145,000
Q1 2021 May 17, 2021	BUY	$4.17 - $6.73 $46,704 - $75,376	11,200 New	11,200 $58,000
Q4 2020 Feb 16, 2021	SELL	$4.65 - $7.79 $81,375 - $136,325	-17,500 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$4.12 - $9.09 $25,956 - $57,267	-6,300 Reduced 26.47%	17,500 $85,000
Q2 2020 Aug 14, 2020	BUY	$1.84 - $6.44 $11,960 - $41,860	6,500 Added 37.57%	23,800 $116,000
Q1 2020 May 15, 2020	BUY	$1.54 - $6.75 $9,702 - $42,525	6,300 Added 57.27%	17,300 $38,000
Q4 2019 Feb 14, 2020	BUY	$3.06 - $8.78 $33,660 - $96,580	11,000 New	11,000 $64,000

Others Institutions Holding AQST

# of Institutions

122

Shares Held

46.8M

Call Options Held

517K

Put Options Held

207K

Bratton Capital Management, L.P. Fort Worth, TX

9.81M
Shares

$48.7 Million
100.0% of portfolio
Vr Adviser, LLC New York, NY

5.56M
Shares

$27.6 Million
2.87% of portfolio
Black Rock Inc. New York, NY

5.45M
Shares

$27.1 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

4.26M
Shares

$21.1 Million
0.0% of portfolio
Franklin Resources Inc San Mateo, CA

2.77M
Shares

$13.7 Million
0.0% of portfolio

View Full List

About Aquestive Therapeutics, Inc.

Ticker AQST
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 53,350,700
Market Cap $265M
Description
Aquestive Therapeutics, Inc., a pharmaceutical company, focuses on identifying, developing, and commercializing various products to address unmet medical needs in the United States and internationally. The company markets Sympazan, an oral soluble film formulation of clobazam for the treatment of lennox-gastaut syndrome; Suboxone, a sublingual f...

More about AQST

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account